Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.


CPS and the Scottish government agreed to begin negotiations with the initial focus on reimbursement arrangements to prevent a delay on this part of the deal, whilst discussions on the Global Sum element of remuneration continue.

The guaranteed reimbursement figure has seen steady increases in recent years, previously rising from £100 million in 2023/24 to £110 million in 2024/25.

In addition, the value mapped from the Scottish Drug Tariff has been increased by £20 million, from £80 million to £100 million, which CPS confirmed will be delivered as “guaranteed service income.”

CPS chief executive Matt Barclay said: "We agreed with Scottish Government to work on what we could with the financial package when we could.”

“This is effectively the first part of the deal, supporting network cashflow in the event of a medicines market downturn linked to the Drug Tariff through the Guaranteed Minimum and crucially mapping further guaranteed money to support strategic service lines for patients.”

“We are continuing to work hard to get more resource into the contract in line with the CPS Board objectives for 25/26.”

Olivier Picard, chair of the National Pharmacy Association (NPA), welcomed the agreement as “good news” for pharmacies across Scotland, stating that it will help maintain “a strong network amid rising costs.”

“National insurance and national minimum wage increases have added to the pressures facing pharmacies alongside growing medicine costs and inflation that has affected every business in Scotland.”

“It is reassuring that CPS will be closely monitoring pharmacies’ cashflow to ensure our sector remains sustainable.”

He emphasised that the pharmacy network is vital for millions of people who rely on it for medicines, health advice and treatment on their doorsteps.

“So, it’s important to see commitment from the Scottish Government to maintaining this crucial service and seeing it flourish in the years ahead.”

CPS welcomed the recognition given to the pharmacy network in the recently published First Minister’s NHS Operational Improvement Plan, which acknowledges the key role of pharmacies in delivering NHS Pharmacy First Scotland.

“CPS are delighted to see that the network's huge contribution to patient care is being noticed by government and expansion sought to deliver even more care through our reliable network.”

“The CPS Team will work to meet the commitment made in the plan and improve access to care through the pharmacy network,” it added.

Further announcements regarding the complete financial settlement for 2025/26 are expected in due course, as negotiations continue.

More For You

Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less
Community pharmacies falling behind on data security toolkit submissions

The last date for submission is 30 June 2025.

Pic credit: iStock

Community pharmacies falling behind on data security toolkit submissions

More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.

Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.

Keep ReadingShow less
Digital guide launched to help patients with osteoporosis

In the UK, over three million people have osteoporosis.

Pic credit: iStock

Digital guide launched to help patients with osteoporosis

The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.

After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication.

Keep ReadingShow less
GPhC five-year plan to empower pharmacists, uphold public trust

GPhC's Strategic Plan 2025-30 will focus on empowering pharmacists and pharmacy technicians.

iStock

GPhC five-year plan to empower pharmacists, uphold public trust

The General Pharmaceutical Council (GPhC) launched its new plan for the next five years to uphold safety, quality and public trust in pharmacy.

The regulatory body unveiled its Strategic Plan 2025-30 during a Parliamentary event attended by pharmacy minister Stephen Kinnock on Wednesday (18).

Keep ReadingShow less
Glucose monitor and test strips on a blood sugar tracker sheet with lancets and pen device.

Medical device manufacturers will have to monitor the safety and performance of their products already in use.

iStock

Medical device regulation overhauled to improve patients' safety

Medical device manufacturers must now adhere to the UK's post-market surveillance (PMS) regulations.

The new rule came into effect on June 16, and manufacturers will have to monitor the safety and performance of their products already in use.

Keep ReadingShow less